Sign up to save your podcasts
Or
Share Stephen Lam Chan, MD - Recalibrating Survival: Available and Recently Approved Immunotherapy-Based Combination Approaches in Unresectable HCC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stephen Lam Chan, MD - Recalibrating Survival: Available and Recently Approved Immunotherapy-Based Combination Approaches in Unresectable HCC
Please visit answersincme.com/TZQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in clinical oncology discusses optimizing patient outcomes with immunotherapy-based combination approaches in unresectable hepatocellular carcinoma (HCC). Upon completion of this activity, participants should be better able to: Recognize the role of available and recently approved immunotherapy-based combination regimens for the management of unresectable HCC; Outline the practical implications of the clinical trial data evaluating available and recently approved immunotherapy-based combination regimens for unresectable HCC; and Review a personalized approach to optimize patient outcomes on available and recently approved immunotherapy-based combination regimens, thus enhancing quality of life.
View all episodes
By Answers in CME
5
66 ratings
Please visit answersincme.com/TZQ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in clinical oncology discusses optimizing patient outcomes with immunotherapy-based combination approaches in unresectable hepatocellular carcinoma (HCC). Upon completion of this activity, participants should be better able to: Recognize the role of available and recently approved immunotherapy-based combination regimens for the management of unresectable HCC; Outline the practical implications of the clinical trial data evaluating available and recently approved immunotherapy-based combination regimens for unresectable HCC; and Review a personalized approach to optimize patient outcomes on available and recently approved immunotherapy-based combination regimens, thus enhancing quality of life.
More shows like CME in Minutes: Education in Oncology & Hematology
View all
Planet Money
30,683 Listeners
Journal of Clinical Oncology (JCO) Podcast
40 Listeners
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
12 Listeners
This Week in Cardiology
881 Listeners
Oncology Today with Dr Neil Love
57 Listeners
CCO Oncology Podcast
9 Listeners
CME in Minutes: Education in Dermatology
3 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners
CME in Minutes: Education in Ophthalmology
0 Listeners
CME in Minutes: Education in Cardiology & Pulmonology
3 Listeners
CME in Minutes: Education in Primary Care
6 Listeners
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
5 Listeners